Free Trial
NYSE:HQL

abrdn Life Sciences Investors (HQL) Stock Price, News & Analysis

abrdn Life Sciences Investors logo
$12.80 +0.02 (+0.16%)
As of 03:58 PM Eastern

About abrdn Life Sciences Investors Stock (NYSE:HQL)

Key Stats

Today's Range
$12.73
$12.83
50-Day Range
$11.98
$13.03
52-Week Range
$10.55
$15.90
Volume
88,622 shs
Average Volume
106,966 shs
Market Capitalization
$369.54 million
P/E Ratio
N/A
Dividend Yield
14.77%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Receive HQL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter.

HQL Stock News Headlines

The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.
See More Headlines

HQL Stock Analysis - Frequently Asked Questions

abrdn Life Sciences Investors' stock was trading at $13.12 at the beginning of the year. Since then, HQL shares have decreased by 2.4% and is now trading at $12.80.
View the best growth stocks for 2025 here
.

Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Record date for 6/30 Dividend
5/22/2025
Ex-Dividend for 6/30 Dividend
5/22/2025
Today
6/30/2025
Dividend Payable
6/30/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Finance
Industry
FIN - INVEST FUND
Sub-Industry
Financial Services
Current Symbol
NYSE:HQL
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
-$10.95 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
25,967,000
Market Cap
$368.41 million
Optionable
Not Optionable
Beta
0.73
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:HQL) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners